CD8A and non-small cell lung carcinoma: Previous studies have shown that there was significant disagreement of both PD-L1 expression and CD8+ T-cell infiltration that are critical contributors to the efficacy of ICI between BMs and matched primary tumors in NSCLC (35, 36).